Effect of once versus twice intracoronary injection of allogeneic-derived mesenchymal stromal cells after acute myocardial infarction: BOOSTER-TAHA7 randomized clinical trial.
Armin AttarMohsen Farjoud KouhanjaniKamran HessamiMassoud VosoughJavad KojuriMani RamziSeyed Ali HosseiniMarjan FaghihAhmad MonabatiPublished in: Stem cell research & therapy (2023)
Trial registration: Iranian Registry of Clinical Trials, IRCT20201116049408N1. Retrospectively Registered 20 Nov. 2020, https://en.irct.ir/trial/52357.
Keyphrases
- clinical trial
- phase iii
- acute myocardial infarction
- phase ii
- study protocol
- bone marrow
- stem cell transplantation
- double blind
- open label
- percutaneous coronary intervention
- left ventricular
- randomized controlled trial
- heart failure
- ultrasound guided
- st elevation myocardial infarction
- coronary artery disease
- low dose
- acute coronary syndrome
- high dose